NASDAQ:CVKD | Cash Flow Statement | Cadrenal Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2022-06-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$3.32M
2026-03-31-$2.5M-$3M$1.3M
2025-12-31-$3.04M-$2.57M$0.00$0.00$2.72M
2025-09-30-$2.69M
2025-06-30-$3.67M
2025-03-31-$3.85M-$4.65M$3,251.00-$3,251.00$1.97M
2024-12-31-$4.19M-$1.79M$7.45M
2024-09-30-$2.41M
2024-06-30-$2.39M
2024-03-31-$1.66M-$1.84M$298.00
2023-12-31-$1.14M-$694,445.00$0.00$0.00-$12,500.00
2023-09-30-$1.04M
2023-06-30-$1M
2023-03-31-$5.17M-$1.41M$5.41M
2022-12-31-$5.01M-$290,216.00$1.00-$1.00$219,721.00
2022-09-30-$1.03M
2022-06-30-$502,141.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$13.24M-$12.6M$5,104.00-$5,104.00$6.6M
2024-12-31-$10.65M-$7.36M$6,537.00-$6,537.00$8.98M
2023-12-31-$8.36M-$3.53M$3,254.00-$3,254.00$11.9M
2022-12-31-$6.71M-$1.2M$2,279.00-$2,279.00$1.24M